Skip to content
AnalystLens

EXELON CORP 8-K/A Report, Executive Changes (Mar 6, 2024)

Reports
Leadership Changes·Exhibits & Filings
Filing Date
Filed March 6, 2024
Period End
March 5, 2024
Security
EXC
In the record · 2016–202610-K1110-Q328-K189

EXC filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 189 current reports (8-K) between 2016 and 2026.

  1. Restructuring8-K · Feb ’18Feb ’18
  2. Impairment8-K · Apr ’21Apr ’21
  3. Leadership change8-K · Dec ’22Dec ’22
  4. Leadership change8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K/A filed March 6, 2024. Cited figures are marked; the original filing is the authoritative source.

This 8-K/A filing from Exelon Corporation primarily serves to update information previously disclosed regarding the appointment of Bryan Segedi to the Board of Directors.

While Mr. Segedi's election was effective January 1, 2024, this amendment clarifies his committee assignments. Investors should note that Mr. Segedi will be appointed to the Audit and Risk Committee, effective April 30, 2024.

Key Highlights

  1. Bryan Segedi's committee assignment to the Audit and Risk Committee is now confirmed.
  2. The appointment to the Audit and Risk Committee will be effective April 30, 2024.
  3. This filing is an amendment (8-K/A) to a previous filing on December 6, 2023, concerning Mr. Segedi's board election.
  4. No new financial information or material business developments are reported in this specific filing.

Frequently Asked Questions

  1. What is the main purpose of this 8-K/A filing?

    This filing is an amendment to clarify the committee assignments for newly elected Board member Bryan Segedi, which was not specified in the initial 8-K filing on December 6, 2023.

  2. Which committee will Bryan Segedi join?

    Bryan Segedi has been appointed to serve on the Audit and Risk Committee of the Board of Directors.

  3. When will Bryan Segedi's committee appointment become effective?

    The appointment to the Audit and Risk Committee will be effective April 30, 2024.

  4. Does this filing contain any new financial results or guidance?

    No, this filing specifically addresses an update to director committee assignments and does not include new financial statements or guidance.